That little pill you've been taking for blood sugar? It may be doing more for you than you realize. Metformin, which can cost as little as $5 a month, has been a go-to type 2 diabetes treatment for ...
A low-cost antidepressant may offer new hope for people struggling with long COVID fatigue. In a randomized clinical trial ...
For decades, Metformin has been the foundation of type 2 diabetes treatment. Affordable, widely available, and backed by years of evidence, it remains the firs ...
As weight loss injectables become more widely available, many people wonder whether metformin is now outdated or whether ...
A landmark global consensus involving 56 academic, clinical, and patient organisations across all world regions has proposed ...
Social media has fueled interest in anti-aging strategies, but evidence continues to support exercise and adequate sleep over ...
MedPage Today on MSN
Study Compares GLP-1 Drugs on Their Benefits, Harms
Quality-of-life effects still a major unknown, researchers say ...
New York Post may receive revenue from affiliate and advertising partnerships for sharing this content and/or when you make a purchase. Could aging be optional? According to renowned biological aging ...
GLP-1 receptor agonists (GLP-1 RA) medications were shown to reduce the number of deaths, amputations and hospitalizations ...
The Diabetes Prevention Program (DPP) and its long-running follow-up, the Diabetes Prevention Program Outcomes Study (DPPOS), have tracked thousands of people for more than two decades, examining how ...
GLP-1 receptor agonists were associated with a higher risk for eye complications vs. other diabetes medications, two studies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results